The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats

Br J Pharmacol. 1988 Jun;94(2):285-7. doi: 10.1111/j.1476-5381.1988.tb11527.x.

Abstract

The behavioural effects of the selective NK-3 tachykinin receptor agonist senktide were studied following intracisternal and subcutaneous administration in rodents. Behavioural manifestations of 5-hydroxytryptaminergic stimulation, including head twitches (mice), wet dog shakes (rats), forepaw treading, flat body posture, hindlimb splaying and Straub tail, were seen following the intracisternal (0.01-1.2 nmol) or subcutaneous (0.1-2.4 mumol kg-1) administration of senktide in both species. We conclude that stimulation of NK-3 receptors stimulates 5-hydroxytryptaminergic pathways in rodent brain, and that senktide may cross the blood-brain barrier in biologically significant amounts.

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Female
  • Injections, Subcutaneous
  • Male
  • Mice
  • Mice, Inbred Strains
  • Peptide Fragments*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Neurotransmitter / drug effects*
  • Receptors, Tachykinin
  • Serotonin / physiology*
  • Substance P / administration & dosage
  • Substance P / analogs & derivatives*
  • Substance P / pharmacology

Substances

  • Peptide Fragments
  • Receptors, Neurotransmitter
  • Receptors, Tachykinin
  • senktide
  • Serotonin
  • Substance P